Related Experiment Video
Updated: Jun 21, 2026
06:42
Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
Published on: September 2, 2025
Clinical and pathologic differences between BRCA1-, BRCA2-, and non-BRCA-associated breast cancers in a multiracial
Cheng-Har Yip1, N A Taib, W Y Choo
1Department of Surgery, University Malaya Medical Centre, 50603, Kuala Lumpur, Malaysia. yipch@um.edu.my
World Journal of Surgery
|August 4, 2009
Summary
BRCA1 mutations in breast cancer are linked to distinct tumor features, like triple-negative status, in Asian women. BRCA2 mutations showed similar tumor characteristics to non-BRCA cancers, suggesting different management strategies may be needed.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Mutations in BRCA1 and BRCA2 genes significantly increase breast cancer risk.
- Limited research exists on BRCA1/BRCA2-associated cancers within Asian populations.
- Malaysia's diverse ethnic makeup (Malays, Chinese, Indians) presents a unique demographic for this study.
Purpose of the Study:
- To investigate differences in tumor pathology and clinical features of breast cancer in relation to BRCA mutations among Malaysian women.
- To compare characteristics of BRCA1- and BRCA2-associated breast cancers with non-BRCA-associated cancers in this population.
Main Methods:
- Retrospective review of medical records for 152 female breast cancer patients who underwent genetic testing for BRCA mutations.
- Data collection included self-reported ethnicity, age at onset, clinical stage at diagnosis, and tumor pathology.
- Analysis focused on comparing tumor features between BRCA mutation carriers and non-carriers.
Main Results:
- Germline deleterious mutations were identified in 31 patients (16 BRCA1, 15 BRCA2).
- Tumors in BRCA1 carriers were more frequently estrogen receptor (ER)-negative and progesterone receptor (PR)-negative.
- HER2 negativity was observed in both BRCA1 and BRCA2 carriers compared to non-BRCA subjects.
- A strong association was found between triple-negative breast cancer and BRCA1 carriers.
- Tumors in BRCA1 carriers tended to be higher grade, though not statistically significant compared to BRCA2 and non-BRCA carriers.
Conclusions:
- Breast cancers associated with BRCA1 mutations exhibit distinct pathological features compared to BRCA2- and non-BRCA-associated cancers.
- Tumors linked to BRCA2 mutations appear similar to those in non-BRCA-associated breast cancers.
- Further research is needed to ascertain differential prognoses and optimal management strategies for each patient group.
Related Concept Videos
01:29Bias in Epidemiological Studies
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...